1. Home
  2. AVTX vs FRD Comparison

AVTX vs FRD Comparison

Compare AVTX & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • FRD
  • Stock Information
  • Founded
  • AVTX 2011
  • FRD 1965
  • Country
  • AVTX United States
  • FRD United States
  • Employees
  • AVTX N/A
  • FRD N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • FRD Steel/Iron Ore
  • Sector
  • AVTX Health Care
  • FRD Industrials
  • Exchange
  • AVTX Nasdaq
  • FRD Nasdaq
  • Market Cap
  • AVTX 90.9M
  • FRD 99.3M
  • IPO Year
  • AVTX 2015
  • FRD N/A
  • Fundamental
  • Price
  • AVTX $10.13
  • FRD $14.96
  • Analyst Decision
  • AVTX Buy
  • FRD
  • Analyst Count
  • AVTX 2
  • FRD 0
  • Target Price
  • AVTX $35.00
  • FRD N/A
  • AVG Volume (30 Days)
  • AVTX 59.3K
  • FRD 11.1K
  • Earning Date
  • AVTX 11-07-2024
  • FRD 11-12-2024
  • Dividend Yield
  • AVTX N/A
  • FRD 1.14%
  • EPS Growth
  • AVTX N/A
  • FRD N/A
  • EPS
  • AVTX N/A
  • FRD 1.14
  • Revenue
  • AVTX $820,000.00
  • FRD $469,515,000.00
  • Revenue This Year
  • AVTX N/A
  • FRD N/A
  • Revenue Next Year
  • AVTX N/A
  • FRD N/A
  • P/E Ratio
  • AVTX N/A
  • FRD $11.93
  • Revenue Growth
  • AVTX N/A
  • FRD N/A
  • 52 Week Low
  • AVTX $3.95
  • FRD $11.15
  • 52 Week High
  • AVTX $34.46
  • FRD $19.52
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 37.71
  • FRD 54.43
  • Support Level
  • AVTX $12.00
  • FRD $13.40
  • Resistance Level
  • AVTX $13.59
  • FRD $15.17
  • Average True Range (ATR)
  • AVTX 0.96
  • FRD 0.69
  • MACD
  • AVTX -0.50
  • FRD 0.02
  • Stochastic Oscillator
  • AVTX 17.42
  • FRD 59.81

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: